The new Ozempic? Weight-loss pill Amycretin could be more effective than jabs
In one of the trials, 125 adults were assigned to weekly injections of amycretin. Those receiving the 60 milligram dose lost nearly a quarter of their body weight over 36 weeks.
This would make amycretin a more effective than other weight loss drugs like Wegovy, where a trial found that patients lost 15 per cent of their body weight over a longer 68 week period.
Another trial enrolled 144 adults to test the pill version of amycretin. Those who took the 100 milligram daily tablet lost an average of 13.1 percent of their weight over 12 weeks.
While jabs like Ozempic, Wegovy and Mounjaro only target the body's GLP-1 receptors, amycretin targets them as well as the amylin receptors, which help regulate blood glucose levels and appetite. The drug helps to prevent overeating and promote feelings of satiety.
The findings were published in The Lancet and presented this week at the American Diabetes Association's Scientific Sessions in Chicago. Researchers also reported that the drug appeared to improve participants' blood sugar control, an important marker for those at risk of developing Type 2 diabetes.
Novo Nordisk, the Danish pharmaceutical company behind amycretin — and also the maker of Wegovy and Ozempic — hopes the pill version of amycretin could make weight-loss therapy more accessible, especially in Britain, where around 1.5 million people currently receive weight-loss treatments, mostly as injections prescribed through specialised clinics or by private providers.
Pill formulations may simplify prescribing and make long-term weight-loss support easier to scale up. Unlike drugs like Ozempic, amycretin tablets would not need to be refrigerated and do not require syringes.
However, amycretin remains in the early stages of clinical testing and that larger trials will be required to fully establish its safety and efficacy.
Both forms of the drug were also associated with improvements in blood sugar levels. Patients did report side effects, including nausea and vomiting, but researchers said that they tended to resolve as the treatment progressed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
‘Fat jabs left me so depressed it was like having The Deer Hunter theme on repeat in my head'
I can say without any doubt that I've never been depressed. So when I began using weight-loss injections three months ago it was a huge shock to find that rather than my usual unhappy-go-lucky self, I sensed something new. Something really bad. I was depressed and I could only assume it was a side effect of the drugs. Within a week of my first injection I felt a deep despair, seemingly from nowhere. Nothing had happened in my work or social life to trigger it. For a few days I searched for a cause, confused and concerned about where this blackness had come from. Suddenly, to an almost absurd, comical extent, existence seemed bleak and irredeemable. It was like having the theme tune to 1978's war drama The Deer Hunter playing in my head on repeat. After the initial shock, I had to somehow find a way to recognise this state for what it was: artificially induced – the mental equivalent of fake news. I have known lots of people with 'real' depression: the kind that keeps a person in bed for a week as if there were a weight tied to their body. The kind that waxes and wanes without reason, making it hard for those around them to empathise. I'd never known that feeling, yet here it was squatting on top of me day after day. Using weight-loss injections produced no other side effects. I have been sleeping well, I've not felt any nausea and I have undoubtedly lost weight, which was the whole point of this expensive experiment in the first place. Much of what has been written about the mental health impact of these treatments has been on either the positive effects of losing weight – improved self esteem – and how some who experience ADHD report a heightened sense of focus and concentration. Nowhere in the literature of the companies that make the treatments, or those who sell it, is there any suggestion that depression is a verifiable risk. Side effects are listed as nausea and vomiting, constipation, diarrhaea, reflux, headaches and fatigue. So much the same as a long stag weekend, rather than a continuous vigil at the edge of the abyss. The medications in question are known as 'glucagon-like peptide-1 receptor agonists' (examples are semaglutide in Ozempic and Wegovy, and tirzepatide in Mounjaro). They were conceived as a treatment for diabetes and were later found to have beneficial effects fighting obesity. They may also help with cardiovascular disease and even neurological disorders such as Alzheimer's. They work by mimicking the effects of the hormone GLP-1, which helps regulate blood sugar levels and appetite. Dr Riccardo De Giorgi, Clinical Lecturer in General Adult Psychiatry at the University of Oxford is currently studying the effects of these drugs and admits that it is too soon to know if there is a possible link with depression, but suggests evidence points to a positive, rather negative, impact on mental health. 'The most recent studies available suggest that GLP-1 medications do not increase depressive symptoms or suicidality,' he says. 'These are based on drug trials where the patients were measured for depression 'scores' and psychological wellbeing, and they didn't show a negative effect overall. 'What happens if you are exposed to these drugs and you have a history of depressive episodes? In that regard, we don't have any evidence at all. There are now some more trials pending on depression, but it's very early days.' I asked around amongst friends and friends of friends (there are so many people using these treatments now that they aren't hard to find), and several reported very similar experiences to my own. One mentioned feeling 'oversensitive and on the verge of tears all the time'. Another said she felt so depressed and exhausted through emotional stress that she had to stop using it. She wanted to start using jabs again but was afraid of reliving her depression. A third said the worst days were 'shocking' but eventually she began to feel better – whether that was because the effects wore off or because she became more adept at coping she couldn't be sure. For me, the strangest feature of this self-inflicted ordeal was that I couldn't trust my emotions. It was like I was in my own matrix, where what I was experiencing felt real but was actually a simulation I had brought on myself – all while paying a monthly fee for the privilege. When something bothered me at work, there was no way to measure its real importance, which meant there was no reliable way to respond to it. How could I tell if a crisis at home was trivial, a total catastrophe or something in between? Thinking about the terrible state of Britain and the world suddenly felt deeply personal rather than an essential part of my job. Just hearing the first bars of a John Barry film score or recalling a random memory of my daughters set me off like Adele at an awards ceremony. I wondered if my new mood was connected to missing food, since I had become a one-meal a day person with no snacking. Maybe giving up eating for pleasure was getting me down? But while I love food like Keir Starmer loves free glasses, not even giving up crisps could make me feel this hopeless. The accepted routes for treating 'real' depression do not really apply to me since all I needed to do was stop the injections. I could hardly start taking anti-depressants to cope with the artificially induced depression brought on by other drugs. Therapy to treat it also seemed ridiculous, since it would be treating something that I had the power to stop. That was not a luxury afforded to those unlucky enough to experience the real thing. The therapists I asked about this were none the wiser, expressing confusion about how they might treat a patient who believed their depression had been triggered not by a pre-existing condition or circumstance, but by weight-loss injections. For me, feeling this way was my choice: a trade off for a thinner waist and a current drop of 1st 9lbs. Dr De Giorgi offered one explanation, yet admits that until he and others are able to conclude further research there is still no clinical evidence of a link between the drugs and depression. 'Some forms of depression are associated with high levels of inflammatory molecules, in which case the anti-inflammatory effects of GLP-1 medications would be helpful,' he explains. 'For other people, who are less prone to inflammation, the drugs might upset the balance in the body that is already in a sweet spot, so the drugs mean you have 'too little inflammation'. A degree of healthy inflammation is needed for the normal upkeep of brain cells. GLP-1 medications seem to be able to enter the brain, so we shouldn't be surprised if we find there are other implications such as mental effects.' Even if a link was ever proven, which is not likely as things stand, it's hardly going to provide much comfort. Most recently, the icing on this doom-laden cake – the kind a goth would get for his birthday at a Dracula festival in Whitby – was that I began to have nightmares. A mixture of Franz Kafka's brand of horror and Stephen King's It, they were like video nasties in which the lead character shouts: 'This isn't real!' and tries to wake themselves up. After a couple of these, I had to set a deadline to get myself off this stuff. No chiselled jawline is worth this. Kate Moss once famously said: 'Nothing tastes as good as skinny feels', but, for me, it was a case of nothing feels as bad as skinny tastes. Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Yahoo
an hour ago
- Yahoo
This Diet Helps Lower Dementia Risk, And We May Finally Know Why
The Mediterranean diet and others like it have been extensively linked to reducing the risk of disease, cognitive decline, and premature death. Now a new study provides more evidence that this choice of foods can protect against dementia – as well as giving us some clues as to why. A team from Rush University Medical Center in Chicago wanted to look specifically at the MIND (Mediterranean-DASH Intervention for Neurodegenerative Delay) diet, which combines elements of the Mediterranean diet with the DASH (Dietary Approaches to Stop Hypertension) diet. That's a lot of acronyms, but it essentially means lots of vegetables, whole grains, fish, and poultry, and not so much dairy, red meat, and fried food. Related: The researchers investigated links between this balance of food items and hippocampal sclerosis – a condition linked to dementia and Alzheimer's, where neurons die off in the brain's hippocampus. Analyzing the postmortem brains of 809 people for whom diet information had been logged for several years before their death, the study found that those who stuck closest to the MIND diet were less likely to show signs of hippocampal sclerosis. "These findings suggest that consuming a healthy diet, such as the MIND diet, may decrease the likelihood of hippocampal sclerosis and may support hippocampal health," write the researchers in their published paper. The diet's impact on dementia risk has been well established by prior research. This latest study offers fresh insight into a significant part of the reason why that link is there: the foods in the MIND diet appear to protect the hippocampus in particular. Crucial to remembering, learning, and navigating, damage to the hippocampus is closely tied to dementia. While not everyone with hippocampal sclerosis has dementia, or vice versa, there's a significant overlap between the two conditions. The research accounted for a variety of demographic and genetic factors, but isn't enough to prove direct cause and effect. What it does show, together with earlier studies, is a strong probability that dementia risk is to some extent affected by what we eat. "To our knowledge these are the first findings in human studies to report that the association of diet and dementia is partially mediated by hippocampal sclerosis," nutrition epidemiologist Puja Agarwal told Hannah Millington at Newsweek. It's not clear how hippocampal sclerosis gets started, but scientists are continuing to discover more about it, and its connections to dementia. It's not the first time it's been shown that the health of this part of the brain could be affected by diet. Future studies may endeavor to understand why this link exists. It's possible that the anti-inflammatory and antioxidant effects of the foods in the MIND diet are helping to guard the brain's neurons from damage in some way. "To further understand the mechanisms linking diet and nutrients with the overall brain health, investigating diet's relationship with other biomarkers of neuroinflammation and oxidative stress in the brain will be critical," write the researchers. The research has been published in JAMA Network Open. Related News A Signal of Future Alzheimer's Could Hide in The Way You Speak Something Inside Your Gut Could Be Like a Natural Ozempic New Vaccine For Two Deadly Cancers Shows Promise in Clinical Trial Solve the daily Crossword
Yahoo
an hour ago
- Yahoo
New Genetic Test Predicts Children With Future Risk of High BMI
A new test helps predict which kids face the largest genetic risk of a high body mass index (BMI) later in life. That could help parents establish healthy habits early on. The new test, put together by a large team of international researchers, is what's known as a polygenic score or PGS. These scores are used to group genetic variations to predict a certain characteristic, which in this case is BMI. Related: "What makes the score so powerful is its ability to predict, before the age of five, whether a child is likely to develop obesity in adulthood, well before other risk factors start to shape their weight later in childhood," says genetic epidemiologist Roelof Smit, from the University of Copenhagen in Denmark. "Intervening at this point can have a huge impact." It's important to note that the test isn't quite as straightforward as it might sound. For one, genetics only accounts for a relatively small proportion of risk for high BMI. And secondly, a growing body of research is suggesting we move away from BMI as a measure of obesity and health in general. Still, the researchers claim the new PGS test is up to twice as accurate as others of its type. It was built from a database of genetic information collected from more than 5.1 million people. After compiling the test, the researchers then tried it out on several separate health databases, covering hundreds of thousands of individuals. In these datasets, both genetic data and BMI over time had been recorded. The researchers added the PGS to other predictors of BMI, and found that higher PGS scores were associated with greater adult weight gain. The accuracy of the PGS at predicting BMI variation depended on age and ancestry. PGS scores at the age of 5 explained 35 percent of the BMI variation at age 18. For middle-aged Europeans, it accounted for 17.6 percent of the variation. In other groups it was much lower: just 2.2 percent for rural Ugandans, for example. This is probably down to underrepresentation in the training data, and the greater genetic diversity in African populations, the researchers say. Another interesting finding from the study: those with stronger genetic predisposition towards having a higher BMI actually lost more weight during the first year of weight loss programs, although they were also more likely to regain weight later. "Our findings emphasize that individuals with a high genetic predisposition to obesity may respond more to lifestyle changes and, thus, contrast with the determinist view that genetic predisposition is unmodifiable," write the researchers in their published paper. The thinking is that if BMI can be predicted more accurately at an early age, that gives those kids and their parents a bigger window of time to instill healthier habits regarding diet or activity levels, which have the potential to influence BMI. "This new polygenic score is a dramatic improvement in predictive power and a leap forward in the genetic prediction of obesity risk, which brings us much closer to clinically useful genetic testing," says geneticist Ruth Loos, from the University of Copenhagen. The research has been published in Nature Medicine. Related News This Diet Helps Lower Dementia Risk, And We May Finally Know Why A Signal of Future Alzheimer's Could Hide in The Way You Speak Something Inside Your Gut Could Be Like a Natural Ozempic Solve the daily Crossword
